aTyr Pharma

We understand disease never takes a day off and are relentlessly pursuing transformational science in order to make meaningful medicines for people with grave maladies where others fall short. Our potentially life-changing therapies are based on novel biological and therapeutic mechanisms that orchestrate important physiological processes in previously untapped ways. These shared principles galvanize our team of remarkable people who are working to achieve our mission and to provide positive outcomes for patients and other stakeholders throughout every aspect of our business.
Type
Public
HQ
San Diego, US
Size (employees)
55 (est)
aTyr Pharma is headquartered in San Diego, US

aTyr Pharma Office Locations

aTyr Pharma has an office in San Diego
San Diego, US (HQ)
3545 John Hopkins Ct

aTyr Pharma Data and Metrics

aTyr Pharma Financial Metrics

Numbers are in $, USD

Net income (FY, 2016)

(57.9 m)

EBIT (FY, 2016)

(57.9 m)

Market capitalization (26-May-2017)

78.6 m

Closing share price (26-May-2017)

3.4

Cash (31-Dec-2016)

38.4 m
aTyr Pharma's current market capitalization is $78.6 m.
Numbers are in $, USDFY, 2015FY, 2016

R&D expense

34.5 m42.8 m

General and administrative expense

13.1 m15.1 m

Operating expense total

47.6 m57.9 m

EBIT

(47.6 m)(57.9 m)

Interest expense

(386 k)65 k

Interest income

(386 k)65 k

Pre tax profit

(57.9 m)

Income tax expense

49 k

Net Income

(48 m)(57.9 m)
Numbers are in $, USDFY, 2015FY, 2016

Cash

53 m38.4 m

Current Assets

98 m74.8 m

PP&E

1.8 m1.4 m

Total Assets

129.7 m80.5 m

Accounts Payable

3.9 m2.6 m

Total Debt

5.1 m

Current Liabilities

12.1 m8.5 m

Common Stock

24 k

Additional Paid-in Capital

273.3 m278.8 m

Retained Earnings

(158.1 m)(216 m)

Total Equity

115.1 m62.8 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.1 x1.3 x
Numbers are in $, USDFY, 2015FY, 2016

Net Income

(48 m)(57.9 m)

Depreciation and Amortization

869 k900 k

Accounts Receivable

(3.6 m)

Accounts Payable

3.9 m(932 k)

Cash From Operating Activities

(36.8 m)(52.9 m)

Purchases of PP&E

(664 k)(600 k)

Cash From Investing Activities

(72 m)33.5 m

Short-term Borrowings

(3.2 m)(5.2 m)

Long-term Borrowings

(2 m)(2 m)

Cash From Financing Activities

147.9 m4.7 m

Interest Paid

925 k225 k
Y, 2016

Financial Leverage

1.3 x

aTyr Pharma Market Value History

aTyr Pharma Online and Social Media Presence

aTyr Pharma Company Life and Culture

You may also be interested in